These Analysts Revise Their Forecasts On MongoDB After Q4 Results

MongoDB, Inc. MDB reported upbeat fourth-quarter earnings, but issued weak FY25 guidance on Thursday.

MongoDB clocked quarterly earnings of 86 cents per share, which beat the analyst consensus estimate of 47 cents. Quarterly sales clocked in at $458 million, beating the analyst consensus estimate of $433.73 million.

"MongoDB finished fiscal 2024 on a strong note, highlighted by 34% Atlas revenue growth and operating margin improvement of nearly five percentage points year-over-year. We continue to see healthy new workload wins as MongoDB's developer data platform increasingly becomes the standard for modern application development," said Dev Ittycheria, CEO of MongoDB.

MongoDB sees first-quarter earnings between 34 cents and 39 cents per share, versus the 62 cents per share estimate, and revenue between $436 million and $440 million, versus the $447.47 million estimate. The company expects fiscal year 2025 earnings between $2.27 and $2.49 per share, versus the $3.34 per share estimate, and full-year revenue between $1.9 billion and $1,93 billion, versus the $2.03 billion estimate.

MongoDB shares gained 0.6% to close at $412.01 on Thursday.

These analysts made changes to their price targets on MongoDB after the company reported quarterly results.

• Piper Sandler cut the price target on MongoDB from $500 to $480. Piper Sandler analyst Brent Bracelin maintained an Overweight rating.
• Barclays slashed the price target on MongoDB from $478 to $458. Barclays analyst Raimo Lenschow maintained an Overweight rating.
• Needham cut the price target on MongoDB from $495 to $465. Needham analyst Mike Cikos maintained a Buy rating.
• Mizuho cut the price target on MongoDB from $420 to $380. Mizuho analyst Matthew Broome maintained a Neutral rating.
• Wells Fargo slashed the price target on MongoDB from $500 to $450. Wells Fargo analyst Andrew Nowinski maintained an Overweight rating.
• DA Davidson raised the price target on MongoDB from $405 to $430. DA Davidson analyst Rudy Kessinger upgraded the stock from Neutral to Buy.

Read More: Gap, Genesco And 3 Stocks To Watch Heading Into Friday